Related Experiment Video
Updated: Feb 12, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
The involvement of purinergic signalling in obesity
Geoffrey Burnstock1,2,3, Daniela Gentile4
1Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, Melbourne, Victoria, 3010, Australia. g.burnstock@ucl.ac.uk.
Abstract:
Obesity is a growing worldwide health problem, with an alarming increasing prevalence in developed countries, caused by a dysregulation of energy balance. Currently, no wholly successful pharmacological treatments are available for obesity and related adverse consequences. In recent years, hints obtained from several experimental animal models support the notion that purinergic signalling, acting through ATP-gated ion channels (P2X), G protein-coupled receptors (P2Y) and adenosine receptors (P1), is involved in obesity, both at peripheral and central levels. This review has drawn together, for the first time, the evidence for a promising, much needed novel therapeutic purinergic signalling approach for the treatment of obesity with a 'proof of concept' that hopefully could lead to further investigations and clinical trials for the management of obesity.
Insights
Purinergic signaling, involving P2X, P2Y, and P1 receptors, shows promise for treating obesity. This review highlights its potential as a novel therapeutic strategy for managing this global health issue.
Area of Science:
- Pharmacology
- Metabolic Disorders
- Neuroscience
Background:
- Obesity is a global health crisis with increasing prevalence, driven by energy imbalance.
- Current pharmacological treatments for obesity are limited in efficacy.
- Purinergic signaling pathways are implicated in obesity at both peripheral and central levels.
Purpose of the Study:
- To review the evidence linking purinergic signaling to obesity.
- To explore the therapeutic potential of targeting purinergic pathways for obesity treatment.
- To establish a proof of concept for novel anti-obesity strategies.
Main Methods:
- Literature review of experimental animal models.
- Analysis of purinergic signaling mechanisms (P2X, P2Y, P1 receptors).
- Synthesis of evidence on purinergic involvement in energy balance regulation.
Main Results:
- Experimental data suggest purinergic signaling plays a role in obesity.
- ATP-gated ion channels (P2X), G protein-coupled receptors (P2Y), and adenosine receptors (P1) are key players.
- Evidence supports purinergic signaling's involvement at both peripheral and central levels.
Conclusions:
- Purinergic signaling represents a promising novel therapeutic target for obesity.
- Further research and clinical trials are warranted to develop purinergic-based obesity treatments.
- This review provides a foundation for future investigations into purinergic signaling for obesity management.
Related Concept Videos
Obesity
Bacterial Signaling
Endocrine Signaling
What is Cell Signaling?
Drug Dosing: Obese Patients
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...

